{
  "success": true,
  "data": {
    "id": 3524741,
    "linkedin_source_id": "10399839",
    "name": "GRAIL",
    "created_at": "2016-06-22",
    "last_updated": "2025-10-14",
    "websites_main": "https://grail.com",
    "websites_resolved": "https://grail.com/",
    "websites_main_original": "http://www.grail.com",
    "unique_website": true,
    "unique_domain": true,
    "expired_domain": false,
    "websites_linkedin": "https://www.linkedin.com/company/grail-inc.",
    "websites_linkedin_canonical": "https://www.linkedin.com/company/grail-inc.",
    "social_linkedin_urls": [
      "https://www.linkedin.com/company/grail-inc./"
    ],
    "websites_facebook": null,
    "social_facebook_urls": [
      "https://www.facebook.com/grailbio/"
    ],
    "websites_twitter": null,
    "social_twitter_urls": [
      "https://twitter.com/grailbio"
    ],
    "social_x_urls": null,
    "social_instagram_urls": [
      "https://www.instagram.com/grailbio"
    ],
    "social_youtube_urls": null,
    "social_github_urls": null,
    "social_reddit_urls": null,
    "social_discord_urls": null,
    "social_pinterest_urls": null,
    "social_tiktok_urls": null,
    "logo": "/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAMCAgMCAgMDAwMEAwMEBQgFBQQEBQoHBwYIDAoMDAsKCwsNDhIQDQ4RDgsLEBYQERMUFRUVDA8XGBYUGBIUFRT/2wBDAQMEBAUEBQkFBQkUDQsNFBQUFBQUFBQUFBQUFBQUFBQUFBQUFBQUFBQUFBQUFBQUFBQUFBQUFBQUFBQUFBQUFBT/wAARCAAyADIDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD9U6KKKACivEfjL+2N8M/ghqb6VrmrS3utRgGXTNKh8+aHPTzDkIhPozA+1ch4D/4KI/CHxvq0OnzX2o+G5ZWCJNrNsqQbj0DSo7qn1bA961VKbXMlodCw9WUeZRdj6dopqOsqK6MGVhkMDkEU6sjnCiiigArz39oL4gXHwt+C/jHxTaAG903TpJLbcMgTHCRkjuA7Kfwr0KuK+NHw+X4q/CrxT4TMiwvq1hLbRSv91JSMxsfYOFJqo25lfYuFudc21z5R/YB/Z70DX/BUvxQ8W2UXiTxDq97cG1m1NBOIUSQo8uGyDK8gclzkgYAxznqPib8Wf2UvEPiNLXxY2ly6voN+VJXR7hGSaJ8NG7RxASJuUgqSVOOlea/sd/tN6Z8A9P1T4T/FRZvCt5pV7K9tdXUTGOPe254pNoJUbssj42sr9RgZ3fjz8Yf2ZrPS7iXR7Hw5rXiO+uhK9zpOix3L5Z9zs8hTblsnuSSeld8oydV3T8rHrzhOWIbkpNPa3Y+0vCfiXTPGPhrTNc0W4F1pOoW6XNrOEZA8TDKnawBHHYgVrVx3wdaJ/hX4SaCyk06FtMtylpNbfZ3hUoCFMWBsIH8OOK7GvPejPHkrNoKKKKRIUUUUAcJ8RvgZ4C+Lfkt4u8LafrcsI2x3E0ZWdB6CVSHA9s4rF8D/ALLPwp+HOqR6noHgjTLXUYjmO7mVrmWM+qtKzFT7jFeq0VXPJK19DRVJqPKpOwUUUVJmFFFFABRRRQAUUUUAFFFFABRRRQB//9k=",
    "enriched_b2b": 0,
    "ticker": null,
    "exchange": null,
    "description": "Our mission is to detect cancer early, when it can be cured. We are working to change the trajectory of cancer mortality and bring stakeholders together to adopt innovative, safe, and effective technologies that can transform cancer care.\n\nWe are a healthcare company, pioneering new technologies to advance early cancer detection. We have built a multi-disciplinary organization of scientists, engineers, and physicians and we are using the power of next-generation sequencing (NGS), population-scale clinical studies, and state-of-the-art computer science and data science to overcome one of medicine\u2019s greatest challenges.\n\nGRAIL is headquartered in Menlo Park, California, with locations in Washington, D.C., North Carolina, and the United Kingdom. It is supported by leading global investors and pharmaceutical, technology, and healthcare companies. \n\nFor more information, please visit grail.com.\n\nCommunity Guidelines: https://bit.ly/3xigb24",
    "enriched_summary": "GRAIL is a company that specializes in cancer detection and provides services such as multi-cancer early detection, methylation, precision oncology, diagnostic aid for cancer, clinical expertise, clinical studies, manuscripts, presentations, medical education, and external sponsored research.",
    "metadata_title": "Homepage - GRAIL",
    "metadata_description": null,
    "industry": "Biotechnology Research",
    "specialities": [
      "Cancer Detection",
      "Cancer Biology",
      "Clinical Trials",
      "Computer Science",
      "Machine Learning",
      "Data Science"
    ],
    "enriched_keywords": [
      "precision oncology",
      "methylation",
      "diagnostic aid",
      "multi-cancer early detection",
      "cancer detection"
    ],
    "enriched_category": "Healthcare",
    "type": "Privately Held",
    "founded": "2016",
    "size_range": "1001-5000 employees",
    "size_employees_count": 1104,
    "size_employees_count_inferred": 1007,
    "followers": 99497,
    "location_hq_raw_address": "Menlo Park, CA, United States",
    "location_hq_country": "United States",
    "location_hq_regions": [
      "Northern America",
      "Northern America",
      "AMER"
    ],
    "locations_full": [
      {
        "location_address": "1525 O'Brien Drive; Menlo Park, CA 94025, US",
        "is_primary": true
      }
    ],
    "updates": [
      {
        "followers": 99497,
        "date": "7h",
        "description": "While rare, men are at risk for breast cancer and should not ignore any unusual symptoms\u2014like a painless lump, skin dimpling, nipple inversion, redness or scaling, or nipple discharge.\n\nFor Men\u2019s Breast Cancer Awareness Week, we\u2019re urging men to take these warning signs seriously and see their doctor. Early detection can help ensure their treatment success.\n\n#MensBreastCancerAwareness #MenGetBreastCancerToo #EarlyDetection",
        "reactions_count": 18,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 99497,
        "date": "1d",
        "description": "We were honored to welcome leadership from the American Cancer Society Cancer Action Network (ACS CAN) to the GRAIL lab in North Carolina last week.\n\nTheir tireless commitment to improving the status quo and advancing the fight against cancer continues to inspire all of us. Together, we share a vision of a future where early detection is possible for everyone \u2014 saving more lives and changing outcomes for patients and families everywhere.\n\nThank you to the ACS team for your partnership, leadership, and unwavering dedication to making that vision a reality.",
        "reactions_count": 200,
        "comments_count": 1,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 99497,
        "date": "4d",
        "description": "Primary liver cancer is the fourth most common cause of cancer death worldwide, and hepatocellular carcinoma (HCC) accounts for nearly 75% of all cases. Because HCC is often diagnosed in advanced stages, deaths have doubled since 1999, and effective treatments remain limited. For Liver Cancer Awareness Month, we\u2019re raising awareness and promoting early detection.\n\n#OctoberIs4Livers #LiverCancerAwarenessMonth #EarlyDetection",
        "reactions_count": 48,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 99497,
        "date": "1w",
        "description": "Darla, a community service officer serving her local police department for 20 years, took her insurance company up on an offer to take a multi-cancer early detection test (MCED). She was ultimately grateful that this test detected a cancer signal while she was still asymptomatic, enabling swift action, and likely the reason she is cancer free today. https://bit.ly/47aCE3o",
        "reactions_count": 83,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 99497,
        "date": "1w",
        "description": "PATHFINDER 2 is the largest U.S. interventional study of a multi-cancer early detection (MCED) screening test to date, enrolling more than 35,000 participants. Our president, Joshua Ofman MD, MSHS, shares why this study marks an important milestone for MCED and what to expect as results are presented at the upcoming #ESMO25 congress.\n\nRead more: https://bit.ly/46EECck\n#MCED #EarlyDetection #ClinicalTrial",
        "reactions_count": 179,
        "comments_count": 5,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 99497,
        "date": "1w",
        "description": "For Breast Cancer Awareness Month, we\u2019re calling attention to the importance of early detection\u2014especially if you have or are at risk of having the BRCA gene mutation\u2014which can increase your risk for breast cancer. Our podcast, The Cancer SIGNAL, delves into this important topic and is available wherever you listen to podcasts: https://bit.ly/3KrMLbk\n\n#BreastCancerAwarenessMonth #EarlyDetection",
        "reactions_count": 58,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 99497,
        "date": "2w",
        "description": "Happy International Podcast Day! If you\u2019re looking for something new, check out The Cancer SIGNAL podcast available through GRAIL and hosted by cancer survivor Susanna Quinn. On this podcast, we dive into the stories behind multi-cancer early detection (MCED)\u2014from patients to doctors, advocates to researchers, and more. \n\nThe Cancer SIGNAL is available wherever you listen to podcasts: https://bit.ly/463jhaS\n\n#InternationalPodcastDay #PodcastCommunity #EarlyCancerDetection",
        "reactions_count": 33,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 99497,
        "date": "2w",
        "description": "Regular screenings are key to detecting cervical cancer early. This Gynecologic Cancer Awareness Month, we\u2019re reminding everyone that early detection improves a person\u2019s prognosis and chances of being successfully treated.\n\n#GynecologicCancerAwarenessMonth #GCAM",
        "reactions_count": 40,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 99497,
        "date": "2w",
        "description": "Senior VP of Communications for the Dallas Cowboys, Tad Carper, took a multi-cancer early detection (MCED) test during the team\u2019s 2024 training camp\u2014and that sent him on a cancer journey he had never expected. Hear his story about early cancer detection, positive thinking, and paying it forward in the latest episode of The Cancer SIGNAL podcast. \ud83c\udfa7\n\nApple Podcasts: https://apple.co/4mI2WPm \nSpotify: https://bit.ly/46zh9b5 \nTranscripts and more: https://bit.ly/4mtqnvp \n\n#EarlyCancerDetection #MCED",
        "reactions_count": 101,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 99497,
        "date": "2w",
        "description": "We are pleased to present new data from our registrational PATHFINDER 2 study at the upcoming ESMO - European Society for Medical Oncology\u202fCongress in Berlin.\n\nWe also look forward to sharing data from our prospective observational study, SYMPLIFY, and real-world experience of veterans from the REFLECTION study at the Early Detection of Cancer Conference (EDCC) 2025 in Portland.\n\nRead more in our latest press release: https://bit.ly/4nc39Lu\n#ESMO25",
        "reactions_count": 203,
        "comments_count": 2,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 99265,
        "date": "1w",
        "description": "Senior VP of Communications for the Dallas Cowboys, Tad Carper, took a multi-cancer early detection (MCED) test during the team\u2019s 2024 training camp\u2014and that sent him on a cancer journey he had never expected. Hear his story about early cancer detection, positive thinking, and paying it forward in the latest episode of The Cancer SIGNAL podcast. \ud83c\udfa7\n\nApple Podcasts: https://apple.co/4mI2WPm \nSpotify: https://bit.ly/46zh9b5 \nTranscripts and more: https://bit.ly/4mtqnvp \n\n#EarlyCancerDetection #MCED",
        "reactions_count": 78,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 99265,
        "date": "2d",
        "description": "For Breast Cancer Awareness Month, we\u2019re calling attention to the importance of early detection\u2014especially if you have or are at risk of having the BRCA gene mutation\u2014which can increase your risk for breast cancer. Our podcast, The Cancer SIGNAL, delves into this important topic and is available wherever you listen to podcasts: https://bit.ly/3KrMLbk\n\n#BreastCancerAwarenessMonth #EarlyDetection",
        "reactions_count": 44,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 99265,
        "date": "3d",
        "description": "Happy International Podcast Day! If you\u2019re looking for something new, check out The Cancer SIGNAL podcast available through GRAIL and hosted by cancer survivor Susanna Quinn. On this podcast, we dive into the stories behind multi-cancer early detection (MCED)\u2014from patients to doctors, advocates to researchers, and more. \n\nThe Cancer SIGNAL is available wherever you listen to podcasts: https://bit.ly/463jhaS\n\n#InternationalPodcastDay #PodcastCommunity #EarlyCancerDetection",
        "reactions_count": 19,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 99265,
        "date": "1w",
        "description": "Regular screenings are key to detecting cervical cancer early. This Gynecologic Cancer Awareness Month, we\u2019re reminding everyone that early detection improves a person\u2019s prognosis and chances of being successfully treated.\n\n#GynecologicCancerAwarenessMonth #GCAM",
        "reactions_count": 28,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 99265,
        "date": "1w",
        "description": "We are pleased to present new data from our registrational PATHFINDER 2 study at the upcoming ESMO - European Society for Medical Oncology\u202fCongress in Berlin.\n\nWe also look forward to sharing data from our prospective observational study, SYMPLIFY, and real-world experience of veterans from the REFLECTION study at the Early Detection of Cancer Conference (EDCC) 2025 in Portland.\n\nRead more in our latest press release: https://bit.ly/4nc39Lu\n#ESMO25",
        "reactions_count": 187,
        "comments_count": 2,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 99265,
        "date": "1w",
        "description": "According to the CDC, cancer is a leading cause of death among firefighters. These firefighter leaders know the importance of being proactive about their health for themselves, their families, and their teammates.\n\nHear how this led to many of these first responders taking multi-cancer early detection (MCED) tests: https://bit.ly/4lRh9JL",
        "reactions_count": 45,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 99265,
        "date": "2w",
        "description": "Today is World Lymphoma Awareness Day, an ideal time for a reminder to pay attention to unusual signs and symptoms and to get regular medical checkups, especially if you\u2019re considered high risk for lymphoma.\n\nKeep in mind that catching it early will likely allow for more treatment options.\n\n#WorldLymphomaAwarenessDay #WLAD",
        "reactions_count": 32,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 99265,
        "date": "3w",
        "description": "Cindy\u2019s OB-GYN, Dr. Candace Westgate, knew that she had a BRCA1 gene mutation and a family history of cancer. She recommended Cindy take a multi-cancer early detection (MCED) test, which yielded a Cancer Signal Detected result.\n\nWatch Cindy\u2019s story to see how this test detected a cancer signal while she was still asymptomatic: https://bit.ly/3YYaxPB\n\n#EarlyCancerDetection \n\nThe Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative results do occur. Galleri is a screening test and does not diagnose cancer. Diagnostic testing is needed to confirm cancer.",
        "reactions_count": 43,
        "comments_count": 1,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 99265,
        "date": "3w",
        "description": "In observance of Ovarian Cancer Awareness Month, we\u2019re spotlighting a few compelling statistics: While stage I ovarian cancer can be cured in up to 90% of patients, and stage II has a 5-year survival rate of 70%, only 20% of cases are diagnosed at stage I or II, underscoring the importance of early detection.\n\n#OvarianCancer #OCAM",
        "reactions_count": 51,
        "comments_count": 1,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 99265,
        "date": "3w",
        "description": "Eric Fung, MD, PhD, SVP of Clinical Development at GRAIL, will join fellow experts in ctDNA to explore how innovations in liquid biopsy are transforming patient monitoring at #WorldCDx on September 24. Be part of the conversation driving the future of precision oncology\u2014join us at #WorldCDx!\n\nContact us at PharmaBD@grailbio.com to learn about partnership opportunities.\n\n#PrecisionMedicine #liquidbiopsy #tissueFree #methylation #ctDNA",
        "reactions_count": 78,
        "comments_count": 1,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 98739,
        "date": "1h",
        "description": "September is Blood Cancer Awareness Month, and it\u2019s worth noting that while the overall cancer death rate decreased by 34% from 1991 to 2022, the leukemia incidence rate has increased, underscoring the importance of early detection.\n\n#BloodCancerAwareness #Leukemia",
        "reactions_count": 9,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 98739,
        "date": "2d",
        "description": "WATCH: Dr. Daniel Mackey and cancer survivor, Mike, share their experiences with multi-cancer early detection (MCED) testing, as well as care coordination and precision medicine in the Mercy Health system for people like Mike: https://bit.ly/4eDH9oB\n\n#EarlyCancerDetection #PrecisionMedicine",
        "reactions_count": 37,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 98739,
        "date": "1w",
        "description": "All of us at GRAIL are saddened to learn about the passing of\u00a0Bonnie J. Addario, a fierce advocate who made an indelible impact on countless people impacted by lung cancer. Our thoughts are with her family, friends, and all who knew her.",
        "reactions_count": 49,
        "comments_count": 2,
        "reshared_post_author": "GO2 for Lung Cancer",
        "reshared_post_author_url": "https://www.linkedin.com/company/go2forlungcancer",
        "reshared_post_author_headline": null,
        "reshared_post_description": "With heavy hearts, we share the passing of our beloved co-founder and leader of GO2 for Lung Cancer, founder of the Bonnie J. Addario Lung Cancer Foundation, and founder of Addario Lung Cancer Medical Institute, Bonnie J. Addario. \n\nBonnie was an extraordinary woman whose vision, strength, and generosity transformed the lung cancer space forever. Following her own diagnosis, she turned adversity into action\u2014channeling her experience into a movement that put patients first. From patient to powerhouse, Bonnie became a fierce and tireless advocate, giving voice and hope to countless individuals and families impacted by lung cancer. \n\nShe united survivors, caregivers, health care providers, researchers, industry leaders, and policymakers to confront this disease with compassion, innovation, and urgency. \n\nWhile her loss is deeply felt, Bonnie\u2019s legacy lives on\u2014in the lives she touched, the progress she inspired, and the unwavering belief she held: that every person affected by lung cancer matters. \n \nWe honor her by continuing the mission she so passionately led\u2014with courage, love, and hope.",
        "reshared_post_date": "1w",
        "reshared_post_followers": null
      },
      {
        "followers": 98739,
        "date": "3w",
        "description": "Today GRAIL reported second quarter 2025 financial results.\n\nLearn more: https://bit.ly/3JtBmXQ",
        "reactions_count": 36,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 98739,
        "date": "3w",
        "description": "As an adult in good health with no symptoms, Neil was surprised when he received a Cancer Signal Detected result from a multi-cancer early detection (MCED) test.\n\nWatch as this cancer survivor shares his inspiring story: https://bit.ly/3TsdPsl\n\n#EarlyCancerDetection \n\nThe Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative results do occur. Galleri is a screening test and does not diagnose cancer. Diagnostic testing is needed to confirm cancer.",
        "reactions_count": 47,
        "comments_count": 1,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 98739,
        "date": "3w",
        "description": "Firefighters across the country choose to lead by example by proactively managing their health, specifically by taking a multi-cancer early detection (MCED) test.\n\nWatch as they share what fueled their decisions to take a test that could detect a cancer signal despite having no symptoms: https://bit.ly/3Tv7JHy\n\n#EarlyCancerDetection\n\nThe Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative results do occur.",
        "reactions_count": 79,
        "comments_count": 1,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 98739,
        "date": "1mo",
        "description": "On World Lung Cancer Day, we can celebrate some positive news: Deaths from lung cancer continue to decline largely thanks to advances in early detection and treatment.\n\nHear from oncologist Daniel Mackey, MD, who reminds us of the importance of early cancer detection.\n\n#EarlyCancerDetection #WorldLungCancerDay #LungCancerAwareness",
        "reactions_count": 40,
        "comments_count": 1,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 98739,
        "date": "1mo",
        "description": "We will issue second quarter 2025 financial results on Tuesday, August 12, 2025. Register for the live teleconference: https://bit.ly/46ySmWq\n\nSee more details: https://bit.ly/3IRix0H",
        "reactions_count": 29,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 98739,
        "date": "1mo",
        "description": "Today is World Head and Neck Cancer Day\u2014a reminder of the importance of early detection. These cancers are increasingly being diagnosed at later stages when treatment is more difficult. Early detection can potentially uncover these cancers at earlier stages when they may respond better to treatment.\n\n#WorldHeadAndNeckCancerDay #HeadAndNeckCancer #EarlyCancerDetection",
        "reactions_count": 95,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 98739,
        "date": "1mo",
        "description": "Cindy\u2019s OB-GYN, Dr. Candace Westgate, knew that she had a BRCA1 gene mutation and a family history of cancer. She recommended Cindy take a multi-cancer early detection (MCED) test, which yielded a Cancer Signal Detected result.\n\nWatch Cindy\u2019s story to see how this test detected a cancer signal while she was still asymptomatic: https://bit.ly/3YYaxPB\n\n#EarlyCancerDetection\n\nThe Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative results do occur. Galleri is a screening test and does not diagnose cancer. Diagnostic testing is needed to confirm cancer.",
        "reactions_count": 89,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 98445,
        "date": "1w",
        "description": "Today GRAIL reported second quarter 2025 financial results.\n\nLearn more: https://bit.ly/3JtBmXQ",
        "reactions_count": 31,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 98445,
        "date": "1w",
        "description": "As an adult in good health with no symptoms, Neil was surprised when he received a Cancer Signal Detected result from a multi-cancer early detection (MCED) test.\n\nWatch as this cancer survivor shares his inspiring story: https://bit.ly/3TsdPsl\n\n#EarlyCancerDetection \n\nThe Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative results do occur. Galleri is a screening test and does not diagnose cancer. Diagnostic testing is needed to confirm cancer.",
        "reactions_count": 43,
        "comments_count": 1,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 98445,
        "date": "2w",
        "description": "Firefighters across the country choose to lead by example by proactively managing their health, specifically by taking a multi-cancer early detection (MCED) test.\n\nWatch as they share what fueled their decisions to take a test that could detect a cancer signal despite having no symptoms: https://bit.ly/3Tv7JHy\n\n#EarlyCancerDetection\n\nThe Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative results do occur.",
        "reactions_count": 73,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 98445,
        "date": "3w",
        "description": "On World Lung Cancer Day, we can celebrate some positive news: Deaths from lung cancer continue to decline largely thanks to advances in early detection and treatment.\n\nHear from oncologist Daniel Mackey, MD, who reminds us of the importance of early cancer detection.\n\n#EarlyCancerDetection #WorldLungCancerDay #LungCancerAwareness",
        "reactions_count": 37,
        "comments_count": 1,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 98445,
        "date": "3w",
        "description": "We will issue second quarter 2025 financial results on Tuesday, August 12, 2025. Register for the live teleconference: https://bit.ly/46ySmWq\n\nSee more details: https://bit.ly/3IRix0H",
        "reactions_count": 30,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 98445,
        "date": "4w",
        "description": "Today is World Head and Neck Cancer Day\u2014a reminder of the importance of early detection. These cancers are increasingly being diagnosed at later stages when treatment is more difficult. Early detection can potentially uncover these cancers at earlier stages when they may respond better to treatment.\n\n#WorldHeadAndNeckCancerDay #HeadAndNeckCancer #EarlyCancerDetection",
        "reactions_count": 96,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 98445,
        "date": "1mo",
        "description": "Cindy\u2019s OB-GYN, Dr. Candace Westgate, knew that she had a BRCA1 gene mutation and a family history of cancer. She recommended Cindy take a multi-cancer early detection (MCED) test, which yielded a Cancer Signal Detected result.\n\nWatch Cindy\u2019s story to see how this test detected a cancer signal while she was still asymptomatic: https://bit.ly/3YYaxPB\n\n#EarlyCancerDetection\n\nThe Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative results do occur. Galleri is a screening test and does not diagnose cancer. Diagnostic testing is needed to confirm cancer.",
        "reactions_count": 89,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 98445,
        "date": "1mo",
        "description": "Everlywell recently announced they are collaborating with GRAIL to offer the Galleri test, which is now available for request directly on everlywell.com via prescription only. \n\nLearn more below. See Important Safety Information: https://lnkd.in/d_fp9JR5",
        "reactions_count": 127,
        "comments_count": 1,
        "reshared_post_author": "Everlywell",
        "reshared_post_author_url": "https://www.linkedin.com/company/everlywell",
        "reshared_post_author_headline": null,
        "reshared_post_description": "We\u2019re proud to partner with GRAIL to expand access to the Galleri Multi-Cancer Early Detection Test, which is now available through Everlywell.\n\nThe Galleri test screens for a signal shared by 50+ types of cancer, many of which do not have standard recommended screenings today. Early detection saves lives\u2014and together, we\u2019re making it more accessible than ever. Hear from Gabe Gaviola, MD, MPH, Senior Medical Director, Everlywell. \ud83d\udc47\n\n\u201cAs a company that has transformed how people access care for nearly a decade, we know innovation only matters when it\u2019s accessible\u2014and access is what changes lives. We\u2019re empowering people with answers when it matters most.\u201d\n\nLearn more: https://lnkd.in/gwBzMBm6\n\nSee the test: https://lnkd.in/gna69jnz\n\n#EarlyDetection #Cancer #DigitalHealth #Diagnostics",
        "reshared_post_date": "1mo",
        "reshared_post_followers": null
      },
      {
        "followers": 98445,
        "date": "1mo",
        "description": "Jack was surprised when a multi-cancer early detection (MCED) test yielded a Cancer Signal Detected result. Hear more about Jack\u2019s experience as he shares his journey from his first MCED test, through to diagnosis, treatment, and recovery with The Cancer SIGNAL host Susanna Quinn.\n\nApple Podcasts: https://apple.co/4eFEL1x\nSpotify: https://bit.ly/4ePbce0\nTranscripts and more:  https://bit.ly/4nKUX5Q\n\nThe Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative results do occur. Galleri is a screening test and does not diagnose cancer. Diagnostic testing is needed to confirm cancer.",
        "reactions_count": 67,
        "comments_count": 2,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 98445,
        "date": "1mo",
        "description": "As an adult in good health with no symptoms, Neil was surprised when he received a Cancer Signal Detected result from a multi-cancer early detection (MCED) test.\n\nWatch as this cancer survivor shares his inspiring story: https://bit.ly/3TsdPsl\n\n#EarlyCancerDetection\n\nThe Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative results do occur. Galleri is a screening test and does not diagnose cancer. Diagnostic testing is needed to confirm cancer.",
        "reactions_count": 114,
        "comments_count": 10,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 97905,
        "date": "2mo",
        "description": "Jack was enjoying retirement and became interested in taking a multi-cancer early detection (MCED) test when his doctor told him about the test. In Episode 28 of The Cancer SIGNAL podcast, Jack shares with host Susanna Quinn how he felt when a Cancer Signal was detected, eventually leading to a head and neck cancer diagnosis before ever experiencing any symptoms. \n\nCheck out the latest episode of The Cancer SIGNAL to hear their in-depth conversation. \ud83c\udfa7\n\nApple Podcasts: https://apple.co/4n7zwvt\nSpotify: https://spoti.fi/43Liudw\nTranscripts and more: https://bit.ly/4mQHuZE",
        "reactions_count": 59,
        "comments_count": 3,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 97905,
        "date": "6h",
        "description": "Firefighters across the country choose to lead by example by proactively managing their health, specifically by taking a multi-cancer early detection (MCED) test.\n\nWatch as they share what fueled their decisions to take a test that could detect a cancer signal despite having no symptoms: https://bit.ly/3Tv7JHy\n\n#EarlyCancerDetection\n\nThe Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative results do occur.",
        "reactions_count": 18,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 97905,
        "date": "1w",
        "description": "On World Lung Cancer Day, we can celebrate some positive news: Deaths from lung cancer continue to decline largely thanks to advances in early detection and treatment.\n\nHear from oncologist Daniel Mackey, MD, who reminds us of the importance of early cancer detection.\n\n#EarlyCancerDetection #WorldLungCancerDay #LungCancerAwareness",
        "reactions_count": 25,
        "comments_count": 1,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 97905,
        "date": "1w",
        "description": "We will issue second quarter 2025 financial results on Tuesday, August 12, 2025. Register for the live teleconference: https://bit.ly/46ySmWq\n\nSee more details: https://bit.ly/3IRix0H",
        "reactions_count": 25,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 97905,
        "date": "1w",
        "description": "Today is World Head and Neck Cancer Day\u2014a reminder of the importance of early detection. These cancers are increasingly being diagnosed at later stages when treatment is more difficult. Early detection can potentially uncover these cancers at earlier stages when they may respond better to treatment.\n\n#WorldHeadAndNeckCancerDay #HeadAndNeckCancer #EarlyCancerDetection",
        "reactions_count": 84,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 97905,
        "date": "3w",
        "description": "Cindy\u2019s OB-GYN, Dr. Candace Westgate, knew that she had a BRCA1 gene mutation and a family history of cancer. She recommended Cindy take a multi-cancer early detection (MCED) test, which yielded a Cancer Signal Detected result.\n\nWatch Cindy\u2019s story to see how this test detected a cancer signal while she was still asymptomatic: https://bit.ly/3YYaxPB\n\n#EarlyCancerDetection\n\nThe Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative results do occur. Galleri is a screening test and does not diagnose cancer. Diagnostic testing is needed to confirm cancer.",
        "reactions_count": 83,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 97905,
        "date": "3w",
        "description": "Everlywell recently announced they are collaborating with GRAIL to offer the Galleri test, which is now available for request directly on everlywell.com via prescription only. \n\nLearn more below. See Important Safety Information: https://lnkd.in/d_fp9JR5",
        "reactions_count": 123,
        "comments_count": 1,
        "reshared_post_author": "Everlywell",
        "reshared_post_author_url": "https://www.linkedin.com/company/everlywell",
        "reshared_post_author_headline": null,
        "reshared_post_description": "We\u2019re proud to partner with GRAIL to expand access to the Galleri Multi-Cancer Early Detection Test, which is now available through Everlywell.\n\nThe Galleri test screens for a signal shared by 50+ types of cancer, many of which do not have standard recommended screenings today. Early detection saves lives\u2014and together, we\u2019re making it more accessible than ever. Hear from Gabe Gaviola, MD, MPH, Senior Medical Director, Everlywell. \ud83d\udc47\n\n\u201cAs a company that has transformed how people access care for nearly a decade, we know innovation only matters when it\u2019s accessible\u2014and access is what changes lives. We\u2019re empowering people with answers when it matters most.\u201d\n\nLearn more: https://lnkd.in/gwBzMBm6\n\nSee the test: https://lnkd.in/gna69jnz\n\n#EarlyDetection #Cancer #DigitalHealth #Diagnostics",
        "reshared_post_date": "1mo",
        "reshared_post_followers": null
      },
      {
        "followers": 97905,
        "date": "3w",
        "description": "Jack was surprised when a multi-cancer early detection (MCED) test yielded a Cancer Signal Detected result. Hear more about Jack\u2019s experience as he shares his journey from his first MCED test, through to diagnosis, treatment, and recovery with The Cancer SIGNAL host Susanna Quinn.\n\nApple Podcasts: https://apple.co/4eFEL1x\nSpotify: https://bit.ly/4ePbce0\nTranscripts and more:  https://bit.ly/4nKUX5Q\n\nThe Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative results do occur. Galleri is a screening test and does not diagnose cancer. Diagnostic testing is needed to confirm cancer.",
        "reactions_count": 67,
        "comments_count": 2,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 97905,
        "date": "4w",
        "description": "As an adult in good health with no symptoms, Neil was surprised when he received a Cancer Signal Detected result from a multi-cancer early detection (MCED) test.\n\nWatch as this cancer survivor shares his inspiring story: https://bit.ly/3TsdPsl\n\n#EarlyCancerDetection\n\nThe Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative results do occur. Galleri is a screening test and does not diagnose cancer. Diagnostic testing is needed to confirm cancer.",
        "reactions_count": 112,
        "comments_count": 10,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 97905,
        "date": "1mo",
        "description": "July is Sarcoma Awareness Month\u2014a critical time to highlight the importance of early detection in rare cancers. Increased awareness and cancer screenings can lead to earlier diagnoses and better treatment outcomes.\n\n#EarlyCancerDetection #Sarcoma #SarcomaAwarenessMonth",
        "reactions_count": 54,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 97746,
        "date": "1mo",
        "description": "Jack was enjoying retirement and became interested in taking a multi-cancer early detection (MCED) test when his doctor told him about the test. In Episode 28 of The Cancer SIGNAL podcast, Jack shares with host Susanna Quinn how he felt when a Cancer Signal was detected, eventually leading to a head and neck cancer diagnosis before ever experiencing any symptoms. \n\nCheck out the latest episode of The Cancer SIGNAL to hear their in-depth conversation. \ud83c\udfa7\n\nApple Podcasts: https://apple.co/4n7zwvt\nSpotify: https://spoti.fi/43Liudw\nTranscripts and more: https://bit.ly/4mQHuZE",
        "reactions_count": 58,
        "comments_count": 1,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 97746,
        "date": "2d",
        "description": "On World Lung Cancer Day, we can celebrate some positive news: Deaths from lung cancer continue to decline largely thanks to advances in early detection and treatment.\n\nHear from oncologist Daniel Mackey, MD, who reminds us of the importance of early cancer detection.\n\n#EarlyCancerDetection #WorldLungCancerDay #LungCancerAwareness",
        "reactions_count": 12,
        "comments_count": 1,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 97746,
        "date": "4d",
        "description": "We will issue second quarter 2025 financial results on Tuesday, August 12, 2025. Register for the live teleconference: https://bit.ly/46ySmWq\n\nSee more details: https://bit.ly/3IRix0H",
        "reactions_count": 19,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 97746,
        "date": "1w",
        "description": "Today is World Head and Neck Cancer Day\u2014a reminder of the importance of early detection. These cancers are increasingly being diagnosed at later stages when treatment is more difficult. Early detection can potentially uncover these cancers at earlier stages when they may respond better to treatment.\n\n#WorldHeadAndNeckCancerDay #HeadAndNeckCancer #EarlyCancerDetection",
        "reactions_count": 77,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 97746,
        "date": "2w",
        "description": "Cindy\u2019s OB-GYN, Dr. Candace Westgate, knew that she had a BRCA1 gene mutation and a family history of cancer. She recommended Cindy take a multi-cancer early detection (MCED) test, which yielded a Cancer Signal Detected result.\n\nWatch Cindy\u2019s story to see how this test detected a cancer signal while she was still asymptomatic: https://bit.ly/3YYaxPB\n\n#EarlyCancerDetection\n\nThe Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative results do occur. Galleri is a screening test and does not diagnose cancer. Diagnostic testing is needed to confirm cancer.",
        "reactions_count": 76,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 97746,
        "date": "2w",
        "description": "Everlywell recently announced they are collaborating with GRAIL to offer the Galleri test, which is now available for request directly on everlywell.com via prescription only. \n\nLearn more below. See Important Safety Information: https://lnkd.in/d_fp9JR5",
        "reactions_count": 120,
        "comments_count": 1,
        "reshared_post_author": "Everlywell",
        "reshared_post_author_url": "https://www.linkedin.com/company/everlywell",
        "reshared_post_author_headline": null,
        "reshared_post_description": "We\u2019re proud to partner with GRAIL to expand access to the Galleri Multi-Cancer Early Detection Test, which is now available through Everlywell.\n\nThe Galleri test screens for a signal shared by 50+ types of cancer, many of which do not have standard recommended screenings today. Early detection saves lives\u2014and together, we\u2019re making it more accessible than ever. Hear from Gabe Gaviola, MD, MPH, Senior Medical Director, Everlywell. \ud83d\udc47\n\n\u201cAs a company that has transformed how people access care for nearly a decade, we know innovation only matters when it\u2019s accessible\u2014and access is what changes lives. We\u2019re empowering people with answers when it matters most.\u201d\n\nLearn more: https://lnkd.in/gwBzMBm6\n\nSee the test: https://lnkd.in/gna69jnz\n\n#EarlyDetection #Cancer #DigitalHealth #Diagnostics",
        "reshared_post_date": "1mo",
        "reshared_post_followers": null
      },
      {
        "followers": 97746,
        "date": "2w",
        "description": "Jack was surprised when a multi-cancer early detection (MCED) test yielded a Cancer Signal Detected result. Hear more about Jack\u2019s experience as he shares his journey from his first MCED test, through to diagnosis, treatment, and recovery with The Cancer SIGNAL host Susanna Quinn.\n\nApple Podcasts: https://apple.co/4eFEL1x\nSpotify: https://bit.ly/4ePbce0\nTranscripts and more:  https://bit.ly/4nKUX5Q\n\nThe Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative results do occur. Galleri is a screening test and does not diagnose cancer. Diagnostic testing is needed to confirm cancer.",
        "reactions_count": 65,
        "comments_count": 1,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 97746,
        "date": "3w",
        "description": "As an adult in good health with no symptoms, Neil was surprised when he received a Cancer Signal Detected result from a multi-cancer early detection (MCED) test.\n\nWatch as this cancer survivor shares his inspiring story: https://bit.ly/3TsdPsl\n\n#EarlyCancerDetection\n\nThe Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative results do occur. Galleri is a screening test and does not diagnose cancer. Diagnostic testing is needed to confirm cancer.",
        "reactions_count": 105,
        "comments_count": 10,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 97746,
        "date": "3w",
        "description": "July is Sarcoma Awareness Month\u2014a critical time to highlight the importance of early detection in rare cancers. Increased awareness and cancer screenings can lead to earlier diagnoses and better treatment outcomes.\n\n#EarlyCancerDetection #Sarcoma #SarcomaAwarenessMonth",
        "reactions_count": 51,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 97746,
        "date": "1mo",
        "description": "Coming soon! Dallas Cowboys Senior VP of Communications, Tad Carper, recently joined The Cancer SIGNAL podcast host Susanna Quinn to share his recent experience with multi-cancer early detection (MCED) testing. Stay tuned for this new episode. \ud83c\udfa7\n\n#EarlyCancerDetection #TheCancerSignal",
        "reactions_count": 122,
        "comments_count": 2,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 97160,
        "date": "1mo",
        "description": "Jack was enjoying retirement and became interested in taking a multi-cancer early detection (MCED) test when his doctor told him about the test. In Episode 28 of The Cancer SIGNAL podcast, Jack shares with host Susanna Quinn how he felt when a Cancer Signal was detected, eventually leading to a head and neck cancer diagnosis before ever experiencing any symptoms. \n\nCheck out the latest episode of The Cancer SIGNAL to hear their in-depth conversation. \ud83c\udfa7\n\nApple Podcasts: https://apple.co/4n7zwvt\nSpotify: https://spoti.fi/43Liudw\nTranscripts and more: https://bit.ly/4mQHuZE",
        "reactions_count": 55,
        "comments_count": 1,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 97160,
        "date": "16h",
        "description": "Everlywell recently announced they are collaborating with GRAIL to offer the Galleri test, which is now available for request directly on everlywell.com via prescription only. \n\nLearn more below. See Important Safety Information: https://lnkd.in/d_fp9JR5",
        "reactions_count": 76,
        "comments_count": 1,
        "reshared_post_author": "Everlywell",
        "reshared_post_author_url": "https://www.linkedin.com/company/everlywell",
        "reshared_post_author_headline": null,
        "reshared_post_description": "We\u2019re proud to partner with GRAIL to expand access to the Galleri Multi-Cancer Early Detection Test, which is now available through Everlywell.\n\nThe Galleri test screens for a signal shared by 50+ types of cancer, many of which do not have standard recommended screenings today. Early detection saves lives\u2014and together, we\u2019re making it more accessible than ever. Hear from Gabe Gaviola, MD, MPH, Senior Medical Director, Everlywell. \ud83d\udc47\n\n\u201cAs a company that has transformed how people access care for nearly a decade, we know innovation only matters when it\u2019s accessible\u2014and access is what changes lives. We\u2019re empowering people with answers when it matters most.\u201d\n\nLearn more: https://lnkd.in/gwBzMBm6\n\nSee the test: https://lnkd.in/gna69jnz\n\n#EarlyDetection #Cancer #DigitalHealth #Diagnostics",
        "reshared_post_date": "2w",
        "reshared_post_followers": null
      },
      {
        "followers": 97160,
        "date": "2d",
        "description": "Jack was surprised when a multi-cancer early detection (MCED) test yielded a Cancer Signal Detected result. Hear more about Jack\u2019s experience as he shares his journey from his first MCED test, through to diagnosis, treatment, and recovery with The Cancer SIGNAL host Susanna Quinn.\n\nApple Podcasts: https://apple.co/4eFEL1x\nSpotify: https://bit.ly/4ePbce0\nTranscripts and more:  https://bit.ly/4nKUX5Q\n\nThe Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative results do occur. Galleri is a screening test and does not diagnose cancer. Diagnostic testing is needed to confirm cancer.",
        "reactions_count": 28,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 97160,
        "date": "5d",
        "description": "As an adult in good health with no symptoms, Neil was surprised when he received a Cancer Signal Detected result from a multi-cancer early detection (MCED) test.\n\nWatch as this cancer survivor shares his inspiring story: https://bit.ly/3TsdPsl\n\n#EarlyCancerDetection\n\nThe Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative results do occur. Galleri is a screening test and does not diagnose cancer. Diagnostic testing is needed to confirm cancer.",
        "reactions_count": 74,
        "comments_count": 4,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 97160,
        "date": "1w",
        "description": "July is Sarcoma Awareness Month\u2014a critical time to highlight the importance of early detection in rare cancers. Increased awareness and cancer screenings can lead to earlier diagnoses and better treatment outcomes.\n\n#EarlyCancerDetection #Sarcoma #SarcomaAwarenessMonth",
        "reactions_count": 43,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 97160,
        "date": "2w",
        "description": "Coming soon! Dallas Cowboys Senior VP of Communications, Tad Carper, recently joined The Cancer SIGNAL podcast host Susanna Quinn to share his recent experience with multi-cancer early detection (MCED) testing. Stay tuned for this new episode. \ud83c\udfa7\n\n#EarlyCancerDetection #TheCancerSignal",
        "reactions_count": 113,
        "comments_count": 2,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 97160,
        "date": "3w",
        "description": "This Juneteenth, we honor freedom and reflect on the ongoing fight for health equity. Black communities continue to face disparities in cancer detection and outcomes due to systemic barriers in healthcare access, trust, and screening availability.\n\nEarly detection can help save more lives when everyone has the opportunity to benefit from it. Addressing these gaps requires action, awareness, and inclusive solutions that serve all communities equitably.\n\n#Juneteenth #EarlyCancerDetection",
        "reactions_count": 52,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 97160,
        "date": "4w",
        "description": "Today we announced positive top-line performance and safety results from our registrational PATHFINDER 2 study. In PATHFINDER 2, adding Galleri to standard of care screening demonstrated substantially greater additional cancer detection than in the previously published PATHFINDER study. \n\nLearn more: https://bit.ly/3SZU9M6",
        "reactions_count": 259,
        "comments_count": 3,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 97160,
        "date": "1mo",
        "description": "This Pride Month, we\u2019re raising awareness about how members of the LGBTQ+ community face a greater risk of cancer and advanced-stage diagnoses. The LGBTQ+ community often faces unique barriers to cancer screening, including access to health care or fear of discrimination.\n\nHear Dr. Scout on The Cancer SIGNAL podcast discuss cancer screening barriers in the LGBTQ+ community and why inclusive care matters: https://bit.ly/45bUra5\n\n#PrideMonth #CancerDetection #TheCancerSignal",
        "reactions_count": 27,
        "comments_count": 1,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "1mo",
        "description": "I know it\u2019s already June\u2014but I didn\u2019t want to miss the chance to reflect on the incredible energy we brought to AAPI Heritage Month at GRAIL \n\nWe celebrated through meaningful moments that highlighted culture, community, and connection:\n\ud83c\udf89 A lively AAPI-themed trivia session that had us learning and laughing\n\ud83c\udfac A powerful movie night that sparked conversation and reflection\n\ud83d\udc9b A day of volunteering that reminded us how we show up for each other\n\nEach event was a reminder of the richness within the AAPI community and the strength that comes from honoring every voice and story.\n\nHuge thank you to everyone who participated and helped create space for celebration and learning. Let\u2019s carry this momentum forward all year long.\n\n#AAPIHeritageMonth #CultureAndConnection #InclusiveWorkplace #BelongingMatters",
        "reactions_count": 48,
        "comments_count": 4,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 95753,
        "date": "1w",
        "description": "Coming soon! Dallas Cowboys Senior VP of Communications, Tad Carper, recently joined The Cancer SIGNAL podcast host Susanna Quinn to share his recent experience with multi-cancer early detection (MCED) testing. Stay tuned for this new episode. \ud83c\udfa7\n\n#EarlyCancerDetection #TheCancerSignal",
        "reactions_count": 95,
        "comments_count": 2,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 95753,
        "date": "2w",
        "description": "This Juneteenth, we honor freedom and reflect on the ongoing fight for health equity. Black communities continue to face disparities in cancer detection and outcomes due to systemic barriers in healthcare access, trust, and screening availability.\n\nEarly detection can help save more lives when everyone has the opportunity to benefit from it. Addressing these gaps requires action, awareness, and inclusive solutions that serve all communities equitably.\n\n#Juneteenth #EarlyCancerDetection",
        "reactions_count": 48,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 95753,
        "date": "2w",
        "description": "Today we announced positive top-line performance and safety results from our registrational PATHFINDER 2 study. In PATHFINDER 2, adding Galleri to standard of care screening demonstrated substantially greater additional cancer detection than in the previously published PATHFINDER study. \n\nLearn more: https://bit.ly/3SZU9M6",
        "reactions_count": 244,
        "comments_count": 1,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 95753,
        "date": "3w",
        "description": "This Pride Month, we\u2019re raising awareness about how members of the LGBTQ+ community face a greater risk of cancer and advanced-stage diagnoses. The LGBTQ+ community often faces unique barriers to cancer screening, including access to health care or fear of discrimination.\n\nHear Dr. Scout on The Cancer SIGNAL podcast discuss cancer screening barriers in the LGBTQ+ community and why inclusive care matters: https://bit.ly/45bUra5\n\n#PrideMonth #CancerDetection #TheCancerSignal",
        "reactions_count": 27,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 95753,
        "date": "3w",
        "description": "Jack was enjoying retirement and became interested in taking a multi-cancer early detection (MCED) test when his doctor told him about the test. In Episode 28 of The Cancer SIGNAL podcast, Jack shares with host Susanna Quinn how he felt when a Cancer Signal was detected, eventually leading to a head and neck cancer diagnosis before ever experiencing any symptoms. \n\nCheck out the latest episode of The Cancer SIGNAL to hear their in-depth conversation. \ud83c\udfa7\n\nApple Podcasts: https://apple.co/4n7zwvt\nSpotify: https://spoti.fi/43Liudw\nTranscripts and more: https://bit.ly/4mQHuZE",
        "reactions_count": 51,
        "comments_count": 1,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 95753,
        "date": "1mo",
        "description": "On National Cancer Survivors Day, we celebrate the estimated 18 million cancer survivors in the U.S. as of January 2022\u2014a number that is projected to increase to 21.6 million by 2030. Early cancer diagnosis can help improve treatment outcomes, leading to more survivors\u2014about 89% of people diagnosed early reach 5-year survival vs. approximately 21% diagnosed at a later stage.\n\n#EarlyCancerScreening #NationalCancerSurvivorsDay #NCSD2025",
        "reactions_count": 71,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 95753,
        "date": "1mo",
        "description": "Lieutenant McFarland, an active and healthy firefighter of 30 years, was diagnosed with esophageal cancer after first taking a multi-cancer early detection (MCED) test. Because it was caught at stage one, he underwent a minimally invasive procedure to remove the tumor and avoided chemo and radiation. His surgeon, Dr. Robert E. Merritt, said \u201cThe impact of detecting it at an early stage opened the road for him to have a good chance at long-term survival.\u201d \n\n#EarlyCancerDetection #MCED #EsophagealCancer",
        "reactions_count": 204,
        "comments_count": 7,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 95753,
        "date": "1mo",
        "description": "All gave some, some gave all. This Memorial Day, our troops and veterans are at the forefront of our minds, especially those who made the ultimate sacrifice for our country on the battlefield and after due to cancer caused by exposure to toxins.\n\n#MemorialDay #SupportOurTroops #Veterans",
        "reactions_count": 96,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 95753,
        "date": "1mo",
        "description": "Improvements in cancer screening, diagnosis, and treatment have led to longer survival\u2014about 70% of U.S. cancer survivors have lived 5 or more years since their diagnosis. But there is more work to be done. This National Cancer Research Month, our commitment to continuing to conduct more research to help detect cancer earlier when it can be cured has never been stronger.\n\n#NCRM25",
        "reactions_count": 75,
        "comments_count": 1,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "18h",
        "description": "I know it\u2019s already June\u2014but I didn\u2019t want to miss the chance to reflect on the incredible energy we brought to AAPI Heritage Month at GRAIL \n\nWe celebrated through meaningful moments that highlighted culture, community, and connection:\n\ud83c\udf89 A lively AAPI-themed trivia session that had us learning and laughing\n\ud83c\udfac A powerful movie night that sparked conversation and reflection\n\ud83d\udc9b A day of volunteering that reminded us how we show up for each other\n\nEach event was a reminder of the richness within the AAPI community and the strength that comes from honoring every voice and story.\n\nHuge thank you to everyone who participated and helped create space for celebration and learning. Let\u2019s carry this momentum forward all year long.\n\n#AAPIHeritageMonth #CultureAndConnection #InclusiveWorkplace #BelongingMatters",
        "reactions_count": 31,
        "comments_count": 1,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 94610,
        "date": "2d",
        "description": "On National Cancer Survivors Day, we celebrate the estimated 18 million cancer survivors in the U.S. as of January 2022\u2014a number that is projected to increase to 21.6 million by 2030. Early cancer diagnosis can help improve treatment outcomes, leading to more survivors\u2014about 89% of people diagnosed early reach 5-year survival vs. approximately 21% diagnosed at a later stage.\n\n#EarlyCancerScreening #NationalCancerSurvivorsDay #NCSD2025",
        "reactions_count": 51,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 94610,
        "date": "4d",
        "description": "Lieutenant McFarland, an active and healthy firefighter of 30 years, was diagnosed with esophageal cancer after first taking a multi-cancer early detection (MCED) test. Because it was caught at stage one, he underwent a minimally invasive procedure to remove the tumor and avoided chemo and radiation. His surgeon, Dr. Robert E. Merritt, said \u201cThe impact of detecting it at an early stage opened the road for him to have a good chance at long-term survival.\u201d \n\n#EarlyCancerDetection #MCED #EsophagealCancer",
        "reactions_count": 159,
        "comments_count": 3,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 94610,
        "date": "1w",
        "description": "All gave some, some gave all. This Memorial Day, our troops and veterans are at the forefront of our minds, especially those who made the ultimate sacrifice for our country on the battlefield and after due to cancer caused by exposure to toxins.\n\n#MemorialDay #SupportOurTroops #Veterans",
        "reactions_count": 85,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 94610,
        "date": "2w",
        "description": "Improvements in cancer screening, diagnosis, and treatment have led to longer survival\u2014about 70% of U.S. cancer survivors have lived 5 or more years since their diagnosis. But there is more work to be done. This National Cancer Research Month, our commitment to continuing to conduct more research to help detect cancer earlier when it can be cured has never been stronger.\n\n#NCRM25",
        "reactions_count": 64,
        "comments_count": 1,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 94610,
        "date": "3w",
        "description": "Today GRAIL reported first quarter 2025 financial results. Learn more: https://bit.ly/3GV4t5b",
        "reactions_count": 55,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 94610,
        "date": "3w",
        "description": "Today we announced a new partnership with athenahealth, which will offer healthcare providers streamlined ordering of the Galleri multi-cancer early detection (MCED) test. Learn more: https://bit.ly/3SvxyGO",
        "reactions_count": 242,
        "comments_count": 4,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 94610,
        "date": "3w",
        "description": "GRAIL has been recognized as the 2025 Best Overall MedTech Company in the 9th annual MedTech Breakthrough Awards program conducted by MedTech Breakthrough! The mission of this program is to honor excellence and recognize innovation, hard work, and success in a range of health and medical technology categories.",
        "reactions_count": 213,
        "comments_count": 3,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 94610,
        "date": "3w",
        "description": "Currently, only ~20% of ovarian cancers are found at an early stage. And there are also no recommended ovarian cancer screening tests for people who are not exhibiting symptoms and are not at high risk of developing this cancer.\n\nThis World Ovarian Cancer Day, hear our podcast host Susanna Quinn\u2019s personal experience with ovarian cancer: https://bit.ly/4d476hi\n\n#WorldOvarianCancerDay #WOCD2025 #NoWomanLeftBehind #NoPersonLeftBehind #TheCancerSignal",
        "reactions_count": 86,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 94610,
        "date": "1mo",
        "description": "\u201cAs a result of their occupational risk, firefighters need this kind of support. They give so much to us. It\u2019s important that we give back to them.\u201d\n\nThis #InternationalFirefightersDay, see how Community Health Network is partnering with GRAIL to bring the benefits of multi-cancer early detection (MCED) testing to the brave individuals who put their lives on the line for their communities each day. \n\nRx only. See Important Safety Information: http://bit.ly/33m8pFa\n\n#IFFD #FirefightersDay #FightCancer #FirefighterCancer",
        "reactions_count": 74,
        "comments_count": 3,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 93543,
        "date": "1d",
        "description": "\u201cAs a result of their occupational risk, firefighters need this kind of support. They give so much to us. It\u2019s important that we give back to them.\u201d\n\nThis #InternationalFirefightersDay, see how Community Health Network is partnering with GRAIL to bring the benefits of multi-cancer early detection (MCED) testing to the brave individuals who put their lives on the line for their communities each day. \n\nRx only. See Important Safety Information: http://bit.ly/33m8pFa\n\n#IFFD #FirefightersDay #FightCancer #FirefighterCancer",
        "reactions_count": 44,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 93543,
        "date": "4d",
        "description": "Finding bladder cancer early improves the chance that treatment will be successful. But for people at average risk, there is currently no standard screening test for bladder cancer.\n\nThis Bladder Cancer Awareness Month, learn more about how multi-cancer early detection (MCED) testing can help screen for this and other types of cancer, potentially before symptoms appear: https://bit.ly/45wf8ux\n\nRx only. See Important Safety Information: https://bit.ly/45wf8ux \n#BladderCancer #BladderCancerAwarenessMonth",
        "reactions_count": 25,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 93543,
        "date": "5d",
        "description": "This National Oral, Head, and Neck Cancer Awareness Month, watch Jack\u2019s story about how multi-cancer early detection (MCED) testing led to his head and neck cancer (HNC) diagnosis: https://bit.ly/4jpU6UP\n\n#OralCancer #HeadAndNeckCancer",
        "reactions_count": 36,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 93543,
        "date": "6d",
        "description": "We will issue first quarter 2025 financial results on Tuesday, May 13, 2025. Register for the live teleconference: https://bit.ly/4cSEmI9\n\nSee more details: https://bit.ly/42RjYCn",
        "reactions_count": 9,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 93543,
        "date": "1w",
        "description": "April 25 is National DNA Day, which commemorates the discovery of DNA\u2019s double helix in 1953 and the completion of the Human Genome Project in 2003\u2014both of which led to major advancements in cancer research, detection, and treatment.\n\n#NationalDNADay",
        "reactions_count": 45,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 93543,
        "date": "1w",
        "description": "We\u2019re excited to attend the American Association for Cancer Research (AACR) Annual Meeting to present new data findings that highlight real-world evidence with the Galleri multi-cancer early detection (MCED) test. See when and where you can find our data presentations: https://bit.ly/3YD9NQz\n#AACR25",
        "reactions_count": 99,
        "comments_count": 1,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 93543,
        "date": "2w",
        "description": "This Medical Laboratory Professionals Week, we are recognizing the important work our clinical laboratory personnel and professionals do in the fight against cancer. Thank you for your invaluable contribution to our mission. \n\n#MLPW #lab4life #labweek",
        "reactions_count": 166,
        "comments_count": 1,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 93543,
        "date": "4w",
        "description": "According to the Prevent Cancer Foundation , \u201c7 in 10 Americans are behind on at least one routine cancer screening.\u201d This #WorldHealthDay, check out our discussion with PCF CEO Jody Hoyos on the importance of early cancer detection: https://bit.ly/4iZhpFd \n#EarlyCancerDetection",
        "reactions_count": 40,
        "comments_count": 2,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 93543,
        "date": "1mo",
        "description": "Today we had the pleasure of welcoming representatives from several cancer advocacy organizations to our North Carolina site to tour our state-of-the-art lab and meet with senior leaders at GRAIL. It was an incredible opportunity to convene this group and share the innovative work we are accomplishing both in and out of the lab, and explore the work needed to support those impacted by cancer. Together, we're forging a path towards the advancement of early cancer detection - a mission that unites us all. Thank you to everyone who joined us and for all the important work you do.\n\nAmerican Cancer Society Cancer Action Network (ACS CAN) \nAssociation of Cancer Care Centers \nCancer Support Community \nFight Colorectal Cancer \nGO2 for Lung Cancer \nNMQF Action Network\nOvarian Cancer Research Alliance  \nPrevent Cancer Foundation",
        "reactions_count": 383,
        "comments_count": 3,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 93543,
        "date": "1mo",
        "description": "Early detection is key to improving cancer outcomes. Adding multi-cancer early detection (MCED) testing to recommended screenings has the potential to shift the cancer detection paradigm.\n\nLearn more about the benefits of MCED: https://bit.ly/49eiZiN",
        "reactions_count": 107,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 92582,
        "date": "5d",
        "description": "According to the Prevent Cancer Foundation , \u201c7 in 10 Americans are behind on at least one routine cancer screening.\u201d This #WorldHealthDay, check out our discussion with PCF CEO Jody Hoyos on the importance of early cancer detection: https://bit.ly/4iZhpFd \n#EarlyCancerDetection",
        "reactions_count": 24,
        "comments_count": 3,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      }
    ],
    "funding_rounds": [
      {
        "last_round_investors_count": 0,
        "total_rounds_count": 5,
        "last_round_type": "Series D",
        "last_round_date": "2020-06-06",
        "last_round_money_raised": 390000000,
        "cb_url": "https://www.crunchbase.com/funding_round/grail-series-d--d1043fdf"
      }
    ],
    "technologies": [
      {
        "technology": "google tag manager",
        "first_verified_at": "2025-04-08",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "pardot",
        "first_verified_at": "2024-06-04",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "grafana",
        "first_verified_at": "2025-08-05",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "workday",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "google search console",
        "first_verified_at": "2025-08-17",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "redis",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "piwik pro",
        "first_verified_at": "2025-04-08",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "6sense",
        "first_verified_at": "2025-08-24",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "gitlab",
        "first_verified_at": "2025-08-17",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "piwik",
        "first_verified_at": "2025-04-08",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "usertesting",
        "first_verified_at": "2024-06-17",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "optimizely",
        "first_verified_at": "2025-04-08",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "google workspace",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "grpc",
        "first_verified_at": "2025-08-17",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "velocity software",
        "first_verified_at": "2025-08-17",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "recognize",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "jira",
        "first_verified_at": "2025-08-17",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "microservices",
        "first_verified_at": "2025-08-17",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "playwright",
        "first_verified_at": "2025-08-17",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "cdmp",
        "first_verified_at": "2025-08-17",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "angular",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "veeva vault",
        "first_verified_at": "2025-08-31",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "python",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "sonarqube",
        "first_verified_at": "2024-05-20",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "typescript",
        "first_verified_at": "2025-08-17",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "pendo",
        "first_verified_at": "2025-04-08",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "react",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "elastic",
        "first_verified_at": "2025-08-17",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "vmware horizon",
        "first_verified_at": "2025-08-17",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "redux",
        "first_verified_at": "2025-04-08",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "grails",
        "first_verified_at": "2025-08-17",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "sns",
        "first_verified_at": "2024-05-20",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "tableau",
        "first_verified_at": "2025-08-17",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "apache airflow",
        "first_verified_at": "2025-02-18",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "smartsheet",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "bash",
        "first_verified_at": "2025-08-17",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "microsoft",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "snowflake",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "onetrust",
        "first_verified_at": "2025-04-08",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "sd wan",
        "first_verified_at": "2025-08-17",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "django",
        "first_verified_at": "2025-04-08",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "fireeye",
        "first_verified_at": "2025-08-17",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "terraform",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "bazel",
        "first_verified_at": "2025-08-17",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "vimeo",
        "first_verified_at": "2025-08-17",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "labcyte echo",
        "first_verified_at": "2025-08-17",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "dbt",
        "first_verified_at": "2025-08-17",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "semrush",
        "first_verified_at": "2025-04-08",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "ansible",
        "first_verified_at": "2024-05-06",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "linux",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "mysql",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "salesforce",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "qualys",
        "first_verified_at": "2025-08-17",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "sales navigator",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "docker",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "google docs",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "asana",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "javascript",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "pure storage",
        "first_verified_at": "2025-08-17",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "docusign",
        "first_verified_at": "2025-08-05",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "figma",
        "first_verified_at": "2025-10-20",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "datorama",
        "first_verified_at": "2025-08-17",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "splunk",
        "first_verified_at": "2025-08-05",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "mocha",
        "first_verified_at": "2025-08-17",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "uplead",
        "first_verified_at": "2025-09-07",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "coupa",
        "first_verified_at": "2025-08-17",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "openvas",
        "first_verified_at": "2025-08-17",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "datadog",
        "first_verified_at": "2025-03-24",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "kubernetes",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "sprout social",
        "first_verified_at": "2025-04-08",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "snowflake data warehouse",
        "first_verified_at": "2025-08-17",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "nextflow",
        "first_verified_at": "2025-08-17",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "gbg",
        "first_verified_at": "2025-08-17",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "workiva",
        "first_verified_at": "2025-08-17",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "hotjar",
        "first_verified_at": "2025-04-08",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "graphql",
        "first_verified_at": "2025-03-10",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "linkedin",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "qualtrics",
        "first_verified_at": "2024-06-17",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "java",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "looker",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "jenkins",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "netsuite",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "google sheets",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "buildkite",
        "first_verified_at": "2025-08-17",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "pytest",
        "first_verified_at": "2025-09-07",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "linkedin sales navigator",
        "first_verified_at": "2025-08-24",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "intercom",
        "first_verified_at": "2024-05-20",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "microsoft office",
        "first_verified_at": "2025-02-18",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "microsoft powerpoint",
        "first_verified_at": "2025-02-18",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "classifier",
        "first_verified_at": "2025-08-17",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "sql",
        "first_verified_at": "2025-08-17",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "prometheus",
        "first_verified_at": "2025-03-24",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "apache",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "gmail",
        "first_verified_at": "2024-08-26",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "google analytics",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "illumina",
        "first_verified_at": "2025-08-17",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "xactly",
        "first_verified_at": "2024-11-04",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "agilent",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "vmware",
        "first_verified_at": "2025-01-20",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "crazy egg",
        "first_verified_at": "2025-04-08",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "prototype",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "lucidchart",
        "first_verified_at": "2025-10-20",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "centricity",
        "first_verified_at": "2025-10-20",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "crowdstrike",
        "first_verified_at": "2025-04-07",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "pci",
        "first_verified_at": "2025-08-17",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "recorded future",
        "first_verified_at": "2025-08-17",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "php",
        "first_verified_at": "2025-08-05",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "confluence",
        "first_verified_at": "2025-08-17",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "mulesoft",
        "first_verified_at": "2024-05-20",
        "last_verified_at": "2025-10-13"
      },
      {
        "technology": "okta",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2025-09-29"
      },
      {
        "technology": "sentinelone",
        "first_verified_at": "2025-04-07",
        "last_verified_at": "2025-09-29"
      },
      {
        "technology": "git",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2025-09-22"
      },
      {
        "technology": "appsheet",
        "first_verified_at": "2025-08-17",
        "last_verified_at": "2025-08-25"
      },
      {
        "technology": "microsoft office 365",
        "first_verified_at": "2025-03-03",
        "last_verified_at": "2025-08-25"
      },
      {
        "technology": "ubuntu",
        "first_verified_at": "2025-03-03",
        "last_verified_at": "2025-08-25"
      },
      {
        "technology": "servicenow",
        "first_verified_at": "2024-05-06",
        "last_verified_at": "2025-08-25"
      },
      {
        "technology": "centos",
        "first_verified_at": "2025-03-03",
        "last_verified_at": "2025-08-25"
      },
      {
        "technology": "zendesk",
        "first_verified_at": "2025-03-03",
        "last_verified_at": "2025-08-25"
      },
      {
        "technology": "microsoft teams",
        "first_verified_at": "2025-03-03",
        "last_verified_at": "2025-08-25"
      },
      {
        "technology": "red hat",
        "first_verified_at": "2025-03-03",
        "last_verified_at": "2025-08-25"
      },
      {
        "technology": "microsoft azure",
        "first_verified_at": "2025-03-03",
        "last_verified_at": "2025-08-25"
      },
      {
        "technology": "windows server",
        "first_verified_at": "2025-08-17",
        "last_verified_at": "2025-08-25"
      },
      {
        "technology": "zoom",
        "first_verified_at": "2024-04-22",
        "last_verified_at": "2025-08-11"
      },
      {
        "technology": "amp",
        "first_verified_at": "2024-05-20",
        "last_verified_at": "2025-08-11"
      },
      {
        "technology": "podium",
        "first_verified_at": "2024-10-28",
        "last_verified_at": "2025-08-11"
      },
      {
        "technology": "ups",
        "first_verified_at": "2024-08-12",
        "last_verified_at": "2025-08-11"
      },
      {
        "technology": "viewpoint",
        "first_verified_at": "2024-05-20",
        "last_verified_at": "2025-08-11"
      },
      {
        "technology": "juniper",
        "first_verified_at": "2025-01-20",
        "last_verified_at": "2025-08-11"
      },
      {
        "technology": "medium",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2025-08-11"
      },
      {
        "technology": "segment",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2025-08-11"
      },
      {
        "technology": "c",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2025-08-11"
      },
      {
        "technology": "sprint",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2025-08-11"
      },
      {
        "technology": "spring",
        "first_verified_at": "2024-05-20",
        "last_verified_at": "2025-08-11"
      },
      {
        "technology": "signal",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2025-08-11"
      },
      {
        "technology": "sprout",
        "first_verified_at": "2025-04-08",
        "last_verified_at": "2025-08-11"
      },
      {
        "technology": "impact",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2025-08-11"
      },
      {
        "technology": "mix",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2025-08-11"
      },
      {
        "technology": "deputy",
        "first_verified_at": "2025-04-08",
        "last_verified_at": "2025-08-11"
      },
      {
        "technology": "lever",
        "first_verified_at": "2024-05-20",
        "last_verified_at": "2025-08-11"
      },
      {
        "technology": "sketch",
        "first_verified_at": "2025-04-08",
        "last_verified_at": "2025-07-28"
      },
      {
        "technology": "well",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2025-07-28"
      },
      {
        "technology": "tableau server",
        "first_verified_at": "2025-04-08",
        "last_verified_at": "2025-06-12"
      },
      {
        "technology": "amazon redshift",
        "first_verified_at": "2025-04-08",
        "last_verified_at": "2025-06-12"
      },
      {
        "technology": "drift",
        "first_verified_at": "2024-09-09",
        "last_verified_at": "2025-06-12"
      },
      {
        "technology": "saviynt",
        "first_verified_at": "2025-06-12",
        "last_verified_at": "2025-06-12"
      },
      {
        "technology": "postgresql",
        "first_verified_at": "2025-04-08",
        "last_verified_at": "2025-06-12"
      },
      {
        "technology": "iam",
        "first_verified_at": "2024-09-09",
        "last_verified_at": "2025-06-12"
      },
      {
        "technology": "json",
        "first_verified_at": "2025-02-18",
        "last_verified_at": "2025-06-09"
      },
      {
        "technology": "upkeep",
        "first_verified_at": "2024-11-25",
        "last_verified_at": "2025-06-09"
      },
      {
        "technology": "github",
        "first_verified_at": "2024-05-20",
        "last_verified_at": "2025-06-09"
      },
      {
        "technology": "google cloud",
        "first_verified_at": "2024-05-06",
        "last_verified_at": "2025-06-09"
      },
      {
        "technology": "network solutions",
        "first_verified_at": "2025-01-20",
        "last_verified_at": "2025-06-09"
      },
      {
        "technology": "ease",
        "first_verified_at": "2024-05-20",
        "last_verified_at": "2025-06-09"
      },
      {
        "technology": "qlikview",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2025-06-09"
      },
      {
        "technology": "nutanix",
        "first_verified_at": "2025-03-24",
        "last_verified_at": "2025-06-09"
      },
      {
        "technology": "zoominfo",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2025-06-09"
      },
      {
        "technology": "elasticsearch",
        "first_verified_at": "2025-03-24",
        "last_verified_at": "2025-06-09"
      },
      {
        "technology": "slack",
        "first_verified_at": "2024-08-19",
        "last_verified_at": "2025-06-09"
      },
      {
        "technology": "microsoft excel",
        "first_verified_at": "2025-02-18",
        "last_verified_at": "2025-06-09"
      },
      {
        "technology": "new relic",
        "first_verified_at": "2025-03-24",
        "last_verified_at": "2025-06-09"
      },
      {
        "technology": "hunter",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2025-03-17"
      },
      {
        "technology": "apttus",
        "first_verified_at": "2024-05-20",
        "last_verified_at": "2025-02-04"
      },
      {
        "technology": "html",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2024-11-25"
      },
      {
        "technology": "q4",
        "first_verified_at": "2024-05-20",
        "last_verified_at": "2024-11-13"
      },
      {
        "technology": "google hangouts",
        "first_verified_at": "2024-05-20",
        "last_verified_at": "2024-11-13"
      },
      {
        "technology": "influential",
        "first_verified_at": "2024-05-20",
        "last_verified_at": "2024-11-04"
      },
      {
        "technology": "hcm",
        "first_verified_at": "2024-05-06",
        "last_verified_at": "2024-10-28"
      },
      {
        "technology": "wonderware",
        "first_verified_at": "2024-04-22",
        "last_verified_at": "2024-10-21"
      },
      {
        "technology": "factorytalk",
        "first_verified_at": "2024-04-22",
        "last_verified_at": "2024-10-21"
      },
      {
        "technology": "labview",
        "first_verified_at": "2024-04-22",
        "last_verified_at": "2024-10-21"
      },
      {
        "technology": "solidworks",
        "first_verified_at": "2024-04-22",
        "last_verified_at": "2024-10-21"
      },
      {
        "technology": "postman",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2024-10-14"
      },
      {
        "technology": "box",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2024-09-30"
      },
      {
        "technology": "aws lambda",
        "first_verified_at": "2024-07-01",
        "last_verified_at": "2024-08-26"
      },
      {
        "technology": "wordpress",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2024-08-19"
      },
      {
        "technology": "keynote",
        "first_verified_at": "2024-06-10",
        "last_verified_at": "2024-08-05"
      },
      {
        "technology": "highspot",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2024-07-15"
      },
      {
        "technology": "apollo.io",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2024-07-15"
      },
      {
        "technology": "skype",
        "first_verified_at": "2024-05-20",
        "last_verified_at": "2024-07-15"
      },
      {
        "technology": "auth0",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2024-07-15"
      },
      {
        "technology": "litmus",
        "first_verified_at": "2024-06-04",
        "last_verified_at": "2024-07-15"
      },
      {
        "technology": "planview",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2024-07-08"
      },
      {
        "technology": "matlab",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2024-06-17"
      },
      {
        "technology": "juris",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2024-06-17"
      },
      {
        "technology": "g suite",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2024-06-10"
      },
      {
        "technology": "testng",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2024-06-10"
      },
      {
        "technology": "apple pay",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2024-04-04"
      }
    ],
    "phone_numbers": [
      "833-694-2553"
    ],
    "emails": [],
    "pricing_available": false,
    "free_trial_available": false,
    "demo_available": false,
    "is_downloadable": false,
    "mobile_apps_exist": false,
    "online_reviews_exist": false,
    "api_docs_exist": false
  },
  "status_code": 200
}